About Osler Diagnostics
Osler Diagnostics is a Healthcare company based in Oxford (United Kingdom) founded in 2017 by Connor Campbell. Portable electrochemical blood glucose sensors are provided for monitoring. It operates in the Healthcare and Technology sectors. Osler Diagnostics has raised $85 million across 1 funding round from investors including M&G, Oxford Science Enterprises and Braavos. Its chief executive, as recorded, is Connor Campbell. Osler Diagnostics offers products and services including Osler Origin and Osler HemaTap. Its focus areas include Life Sciences, Diabetes, Medical Devices and Monitoring Devices. Its legal entity is OSLER DIAGNOSTICS LIMITED.
Company details
Osler Diagnostics was founded in 2017 in Oxford, United Kingdom, within the medical diagnostics sector. Portable electrochemical blood glucose sensor devices are developed and supplied by the company to facilitate point-of-care testing. Operations focus on innovative sensor technology for glucose monitoring, with leadership provided by Co-Founder and CEO Connor Campbell. The companys domain is oslerdiagnostics.com, supporting its activities in the health technology field.
- Headquarters Oxford, United Kingdom
- Founders Connor Campbell
- SectorsHealthcareTechnology
- Website oslerdiagnostics.com
- Social LinkedIn X YouTube
- Legal Name Osler Diagnostics Limited
- Date of Incorporation 11 Feb, 2016
- Jurisdiction OXFORD, ENGLAND
- Total Equity Funding$85M (USD)
in 1 rounds
- Latest Funding Round$85M (USD), Series C
Nov 2022
- InvestorsM&G
& 3 more
Products & Services of Osler Diagnostics
Osler Diagnostics offers a comprehensive portfolio of products and services, including Osler Origin and Osler HemaTap.
Portable instrument for comprehensive, multiplexed health tests.
Technology for microfluidic blood sample handling in diagnostics.
Apps and channels of Osler Diagnostics
its YouTube channel Osler Diagnostics has 16 subscribers and 1 videos.
Videos from Osler Diagnostics
The most watched videos on Osler Diagnostics's YouTube channel, Osler Diagnostics (16 subscribers). Click a video to play it here.
More on Osler Diagnostics.
Funding Insights of Osler Diagnostics
Osler Diagnostics has successfully raised a total of $85M through 1 strategic funding round. The most recent funding activity was a Series C round of $85 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $85M
- Total Rounds 1
- Last Round Series C — $85M
- First Round $85M
(Nov 2022)
- Investors Count 4
All 1 funding rounds of Osler Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $85M | Series C | – | M&G, Oxford Science Enterprises | – |
4 investors in total: 4 institutional.
Investors in Osler Diagnostics
Osler Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include M&G, Oxford Science Enterprises and Braavos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified asset management firm and private fund focused on debt and equity investments in climate startups, real estate, and multiple sectors | 1931 | mandg.com | London, United Kingdom | |
Investment management services for science ventures are provided in Oxford. | oxfordscienceenterprises.com | Oxford, United Kingdom | ||
Braavos is associated with multiple companies. | braavos.uk | |||
Offers fundamental equity investing and management for institutional clients since 1998. | 1998 | lansdownepartners.com | London, United Kingdom |
Investor details for Osler Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Osler Diagnostics
73 people are tracked at Osler Diagnostics (16 in leadership, 5 in board & advisors, 52 in team).
| Name | Role | Group |
|---|---|---|
Connor Campbell | Co-Founder & CEO | Leadership |
Sarah Malin | Director of Programme Delivery | Leadership |
Tom Parenteau | Chief Commercial Officer | Leadership |
David Edington | Chief Technology Officer | Leadership |
Paul Dixon | Chief Financial Officer | Leadership |
Nuno Reis | Director of Product Innovation | Leadership |
Rob Butcher | Head Of Product Design And Engineering | Leadership |
Guy Cowdry Ceng | Head Of Product Development, Consumables | Leadership |
Ian Mountford | Head Of Supply Chain | Leadership |
Thomas Aldred | Head Of Finance And Operations | Leadership |
Vicki Warland | Head of People | Leadership |
Mauricio Varea | Head of Software | Leadership |
EVA KARRA | Head Of Design Quality Assurance | Leadership |
Adam W. | Head Of Product Development | Leadership |
Kartal Çağatay, M.Sc.Eng | Head of Systems | Leadership |
Robert Marshall | Director, Product Development | Leadership |
David Berry | Chairman | Board & advisors |
Amber Salzman | Non-Executive Director | Board & advisors |
Andre Crawford-Brunt | Non-Executive Director | Board & advisors |
Jim Wilkinson | Non-Executive Director | Board & advisors |
53 more people are available in the full profile.
Complete people profiles for Osler Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Osler Diagnostics
2 dated milestones of Osler Diagnostics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Osler Diagnostics is founded.
- Funding First funding round of $85.0M.
Web traffic of Osler Diagnostics
The website of Osler Diagnostics (oslerdiagnostics.com) receives about 6.7K visits a month.
- Monthly visits6.7K
▲ 68.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Osler Diagnostics
Complete news archive for Osler Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osler Diagnostics
Osler Diagnostics was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Osler Diagnostics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Connor Campbell is the CEO of Osler Diagnostics, as recorded in our data. They have also founded this company.
Osler Diagnostics is a funded company, having raised a total of $85M across 1 funding round to date. The company's 1st funding round was a Series C of $85M, raised on Nov 2022.
Osler Diagnostics was founded in 2017 in Oxford, United Kingdom, within the medical diagnostics sector. Portable electrochemical blood glucose sensor devices are developed and supplied by the company to facilitate point-of-care testing. Operations focus on innovative sensor technology for glucose monitoring, with leadership provided by Co-Founder and CEO Connor Campbell. The companys domain is oslerdiagnostics.com, supporting its activities in the health technology field.
Osler Diagnostics offers Osler Origin and Osler HemaTap.
Osler Diagnostics has 4 investors. Key investors include M&G, Oxford Science Enterprises, Braavos, and Lansdowne Partners.
Osler Diagnostics operates through Osler Diagnostics Limited.